URSINI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 4.331
AS - Asia 2.831
EU - Europa 1.152
SA - Sud America 631
AF - Africa 93
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.074
Nazione #
US - Stati Uniti d'America 4.231
SG - Singapore 970
CN - Cina 668
BR - Brasile 515
VN - Vietnam 358
IT - Italia 250
HK - Hong Kong 223
TR - Turchia 158
DE - Germania 146
PL - Polonia 123
BD - Bangladesh 122
UA - Ucraina 120
GB - Regno Unito 107
FR - Francia 81
ID - Indonesia 76
RU - Federazione Russa 74
SE - Svezia 58
IN - India 53
JP - Giappone 52
FI - Finlandia 47
AR - Argentina 46
ZA - Sudafrica 44
CA - Canada 42
MX - Messico 40
AU - Australia 31
IQ - Iraq 29
EC - Ecuador 25
AT - Austria 22
NL - Olanda 21
IE - Irlanda 19
CO - Colombia 18
PK - Pakistan 18
BE - Belgio 12
CH - Svizzera 12
ES - Italia 12
TN - Tunisia 11
MY - Malesia 10
PH - Filippine 10
UZ - Uzbekistan 10
KE - Kenya 8
LT - Lituania 8
MA - Marocco 8
SA - Arabia Saudita 8
VE - Venezuela 8
KR - Corea 7
PY - Paraguay 7
CL - Cile 6
KZ - Kazakistan 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
ET - Etiopia 5
LB - Libano 5
NP - Nepal 5
AZ - Azerbaigian 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EE - Estonia 4
IL - Israele 4
IR - Iran 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
XK - ???statistics.table.value.countryCode.XK??? 4
CG - Congo 3
DK - Danimarca 3
GR - Grecia 3
KW - Kuwait 3
NO - Norvegia 3
OM - Oman 3
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
GT - Guatemala 2
HR - Croazia 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
KH - Cambogia 2
NG - Nigeria 2
PA - Panama 2
PE - Perù 2
QA - Qatar 2
TH - Thailandia 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BW - Botswana 1
CI - Costa d'Avorio 1
EG - Egitto 1
GY - Guiana 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LS - Lesotho 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MR - Mauritania 1
Totale 9.064
Città #
Fairfield 592
Ashburn 548
Singapore 512
Santa Clara 301
Woodbridge 299
Seattle 279
Houston 233
Wilmington 226
San Jose 214
Hong Kong 210
Beijing 202
Cambridge 192
Izmir 138
Ho Chi Minh City 122
Warsaw 121
Dallas 83
Hanoi 83
Milan 67
Princeton 64
Jacksonville 61
Nanjing 61
New York 61
Ann Arbor 57
Lauterbourg 54
Jakarta 53
Los Angeles 51
São Paulo 48
Tokyo 48
Helsinki 44
Chandler 40
San Diego 37
Council Bluffs 29
London 26
Mexico City 24
Rome 24
Redwood City 23
Shanghai 23
Dong Ket 20
Hangzhou 20
Johannesburg 20
Nanchang 19
Shenyang 19
Dublin 18
Chicago 17
Ferrara 17
Nuremberg 17
Chennai 16
Orem 16
Baghdad 15
Da Nang 15
Melbourne 14
Rio de Janeiro 14
Tianjin 14
Toronto 14
Hebei 13
Montreal 13
Moscow 13
San Francisco 13
Munich 12
Norwalk 12
Atlanta 11
Biên Hòa 11
Brooklyn 11
Frankfurt am Main 11
Poplar 11
Boston 10
Buffalo 10
Denver 10
Guangzhou 10
Carbonia 9
Duque de Caxias 9
Guayaquil 9
Haiphong 9
Jiaxing 9
Ningbo 9
Vienna 9
Falls Church 8
Sydney 8
Tashkent 8
Belo Horizonte 7
Changsha 7
Curitiba 7
Kuala Lumpur 7
Manaus 7
Manchester 7
Mountain View 7
Phoenix 7
Stockholm 7
Amsterdam 6
Bến Tre 6
Naples 6
Paris 6
Porto Alegre 6
Addis Ababa 5
Brasília 5
Bắc Ninh 5
Campinas 5
Can Tho 5
Cattolica 5
Chongqing 5
Totale 5.921
Nome #
Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis 516
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 225
Assessing Pretest Clinical Risk of Pulmonary Thromboembolism in the Emergency Department: Proposal of a Simple Modification to the Wells' Score 195
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study 190
Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis 183
Cardiovascular risk markers and major adverse cardiovascular events in psoriatic arthritis patients 183
Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: A systematic review and meta-analysis 182
Current treatment options for psoriatic arthritis: Spotlight on abatacept 181
Abatacept in psoriatic arthritis: Case report and short review 172
The effect of non-TNF-targeted biologics on vascular dysfunction in rheumatoid arthritis: A systematic literature review 170
Coupled Imaging with [18F]FBB and [18F]FDG in AD Subjects Show a Selective Association Between Amyloid Burden and Cortical Dysfunction in the Brain 168
Complement C3 and fatty liver disease in Rheumatoid arthritis patients: a cross-sectional study 167
Levels and Factors Associated with Resilience in Italian Healthcare Professionals during the COVID-19 Pandemic: A Web-Based Survey 167
Small bowel adenocarcinoma as a complication of celiac disease: clinical and diagnostic features 159
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 159
Correlation between elastosonography and nailfold microvascular alterations in systemic sclerosis patients 158
Safety of treatment options for spondyloarthritis: a narrative review 156
Complement C3 is the strongest predictor of whole-body insulin sensitivity in psoriatic arthritis 153
Acute rhabdomyolysis during treatment with amisulpride and metformin 153
The emerging role of complement c3 as a biomarker of insulin resistance and cardiometabolic diseases: Preclinical and clinical evidence 148
Predicting in-hospital mortality for sepsis: a comparison between qSOFA and modified qSOFA in a 2-year single-centre retrospective analysis 148
CD4+ T-cells lymphocytosis and reduction of neutrophils during treatment with adalimumab: Challenge and dechallenge study 146
Chronobiology of acute pancreatitis in a single Italian centre 146
Biologic drugs in adult onset Still’s disease: a systematic review and meta-analysis of observational studies 145
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis 142
Serum complement C3 and type 2 diabetes in rheumatoid arthritis: A case-control study 142
Metformin and Autoimmunity: A "New Deal" of an Old Drug 141
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 140
Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis 139
Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients 139
Fibromyalgia and obesity: The hidden link 134
Interactions among low dose of methotrexate and drugs used in the treatment of rheumatoid arthritis 132
Plantar fascia enthesopathy is highly prevalent in diabetic patients without peripheral neuropathy and correlates with retinopathy and impaired kidney function 132
Old but good: Modified-release prednisone in rheumatoid arthritis 131
Kaposi's sarcoma after T-cell costimulation blockade with abatacept in rheumatoid arthritis: a case report 130
Efficacy and safety of duloxetine in fibromyalgia 129
Methods for diagnosing bile acid malabsorption: a systematic review 129
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo 128
High prevalence of achilles tendon enthesopathic changes in patients with type 2 diabetes without peripheral neuropathy 127
Nutritional supplementation for osteoarthritis 126
Increased serum IgG antibody response to Merkel cell polyomavirus oncoproteins in patients with autoimmune rheumatic diseases 126
Brain glucose consumption abnormalities in neuro-Behçet's disease: A preliminary 18F-FDG PET/CT study 124
Lymphocutaneous Sporotrichosis during Treatment with Anti-TNF-Alpha Monotherapy 124
Role of positron emission tomography for central nervous system involvement in systemic autoimmune diseases: Status and perspectives 124
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study 124
Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: A F-18 FDG PET/CT study 122
TNF-alpha and insulin-resistance: Metabolic effects of in vivo therapeutic blockade 120
Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab 118
Cardiometabolic comorbidities in autoimmune rheumatic diseases: From pathogenesis to treatment 116
Sudden progression from impaired glucose tolerance to type 2 diabetes after discontinuation of administration of anti-tumor necrosis factor-alpha antibody infliximab 115
Infliximab and insulin resistance 114
Vitamin D deficiency in systemic sclerosis: a possible role of subclinical liver fibrosis? Retrospective analysis from an Italian cohort 113
Ageing effect on 18 F-DOPA and 123 I-MIBG uptake: A cross-sectional study 112
Improvement in insulin resistance after short-term treatment with abatacept: Case report and short review 111
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 108
Insulin-sensiting effects of tumor necrosis factor alpha inhibitors in rheumatoid arthritis: A systematic review and meta-analysis 108
Prevalence of undiagnosed diabetes in rheumatoid arthritis: An OGTT study 102
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 96
Monitoring safety and use of old and new treatment options for type 2 diabetic patients: a two-year (2013–2016) analysis 89
Retrospective analysis of type 2 diabetes prevalence in a systemic sclerosis cohort from southern Italy: Comment on “Reduced incidence of Type 1 diabetes and Type 2 diabetes in systemic sclerosis: A nationwide cohort study” by Tseng et al., Joint Bone Spine 2016;83:307–13 89
Prevalence of celiac disease serological markers in a cohort of Italian rheumatological patients 87
Response to the letter to the editor by Shadmani et al 83
The effect of non–TNF-targeted biologics and small molecules on insulin resistance in inflammatory arthritis 78
The HPA Axis in the pathogenesis of Chronic Fatigue Syndrome 74
Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey 70
Serum complement C3 strongly correlates with whole-body insulin sensitivity in rheumatoid arthritis 68
Totale 9.226
Categoria #
all - tutte 49.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.612


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 0 0 62
2021/2022539 27 42 18 36 40 38 15 61 26 65 43 128
2022/2023233 65 7 22 4 4 8 64 16 16 1 19 7
2023/2024201 15 26 13 7 8 7 9 10 5 2 7 92
2024/20251.422 15 44 121 23 163 185 24 76 207 312 143 109
2025/20264.031 300 297 476 631 496 216 255 259 358 408 230 105
Totale 9.226